GENEWIZ from Azenta Life Sciences provides superior data and high-quality constructs for next generation sequencing, gene synthesis, and sanger sequencing.
Location: United States, New Jersey, South Plainfield
Employees: 501-1000
Founded date: 1999
Mentions in press and media 12
| Date | Title | Description |
| 03.09.2024 | Next Generation Sequencing Market is poised to grow from USD 36.04 billion by 2031: Skyquest Technology | Share Tweet Share Share Email In recent years, next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS i... |
| 12.08.2024 | GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event | BURLINGTON, Mass., Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ... |
| 24.07.2024 | Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast | BURLINGTON, Mass., July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes. The Company will host a confere... |
| 04.06.2024 | Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research | Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass., June 4, 2024 /PRNewswire/ -- Azent... |
| 13.05.2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| 08.05.2024 | Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 | BURLINGTON, Mass., May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2024. Quarter Ended Dollars in millions, except per share data March 31, December 31, March 3... |
| 08.05.2024 | Azenta Announces CEO Succession Plan | CEO Dr. Stephen Schwartz to Retire; Search Underway to Identify Successor BURLINGTON, Mass., May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwa... |
| 07.04.2021 | Brooks Life Sciences and GENEWIZ to Host 2-day Virtual Event Focused on Cell and Gene Therapy, April 7-8, 2021 | Brooks Life Sciences and GENEWIZ to host 2-day virtual event focused on cell and gene therapy April 7-8, 2021 SOUTH PLAINFIELD, N.J. (PRWEB) April 07, 2021 The Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life Sciences, opens... |
| 12.01.2016 | GENEWIZ receives investment from OrbiMed for growth in its DNA sequencing, gene synthesis | A GENEWIZ representative was not available to comment on how much was raised or how the round of financing will be used. OrbiMed recently announced the closing of a major fund, bringing in $950 million with the help of investments from medi... |
| 11.01.2016 | Genewiz Raises Venture Capital Funding | Genewiz, a South Plainfield, NJ-based global genomics services provider, raised a funding round of undisclosed amount. The round was led by OrbiMed, with participation from Ampersand Capital Partners and Prime Value Capital Management (PVCM... |
Show more